Solventum Corporation (SOLV)
Automate Your Wheel Strategy on SOLV
With Tiblio's Option Bot, you can configure your own wheel strategy including SOLV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SOLV
- Rev/Share 48.1792
- Book/Share 20.9362
- PB 3.5142
- Debt/Equity 2.144
- CurrentRatio 1.2244
- ROIC 0.0737
- MktCap 12757007385.0
- FreeCF/Share 0.8443
- PFCF 86.7824
- PE 33.709
- Debt/Assets 0.5184
- DivYield 0
- ROE 0.1164
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | SOLV | UBS | -- | Neutral | -- | $77 | Oct. 1, 2025 |
| Initiation | SOLV | Jefferies | -- | Hold | -- | $80 | Sept. 11, 2025 |
| Upgrade | SOLV | Morgan Stanley | Equal Weight | Overweight | -- | $103 | July 15, 2025 |
| Upgrade | SOLV | Argus | Hold | Buy | -- | $90 | July 1, 2025 |
| Initiation | SOLV | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | June 6, 2025 |
| Upgrade | SOLV | Piper Sandler | Neutral | Overweight | -- | $87 | May 19, 2025 |
| Initiation | SOLV | Mizuho | -- | Neutral | -- | $70 | Dec. 4, 2024 |
| Initiation | SOLV | Stifel | -- | Buy | -- | $82 | Oct. 8, 2024 |
| Initiation | SOLV | Piper Sandler | -- | Neutral | -- | $71 | Oct. 7, 2024 |
| Initiation | SOLV | Wolfe Research | -- | Peer Perform | -- | -- | Sept. 26, 2024 |
News
Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Ampersand as it advances its Address, Navigate, Determine (AND)™ Platform to develop programmed biologics.
Read More
About Solventum Corporation (SOLV)
- IPO Date 2024-04-01
- Website https://www.solventum.com
- Industry Medical - Care Facilities
- CEO Bryan C. Hanson
- Employees 22000